China Pharma Holdings, Inc.
CPHI
$1.43
$0.0151.06%
AMEX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 32.74% | 35.84% | -9.53% | 22.27% | -50.44% |
| Total Depreciation and Amortization | -2.55% | -26.51% | -35.70% | -5.74% | 0.75% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -0.24% | 1,824.39% | -124.17% | -82.66% | 136.39% |
| Change in Net Operating Assets | 53.97% | -81.85% | 217.89% | -2.83% | 168.23% |
| Cash from Operations | 603.63% | -124.23% | 607.45% | 35.35% | 87.58% |
| Capital Expenditure | 100.17% | -198.97% | -311.96% | 132.74% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 55.75% | 91.08% | -- | -- | -- |
| Cash from Investing | 87.78% | 70.32% | -3,066.30% | 132.74% | -- |
| Total Debt Issued | -- | -- | 0.00% | -98.66% | -- |
| Total Debt Repaid | -1,223.05% | -- | -- | 100.00% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -200.00% | -- | -- | -- | -200.00% |
| Cash from Financing | 58.29% | -1,129.41% | 0.00% | -1.45% | 0.00% |
| Foreign Exchange rate Adjustments | -633.33% | 91.59% | -729.41% | 282.14% | 16.42% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 199.11% | -133.33% | -345.63% | 79.30% | 82.99% |